Nova Eye Medical Limited
ELXMF
$0.00
-$0.10-98.10%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.32% | 6.23% | -2.12% | 34.59% | 2.74% |
| Total Depreciation and Amortization | 0.32% | -71.54% | 2.13% | 196.79% | -2.75% |
| Total Amortization of Deferred Charges | 0.29% | 209.18% | -2.14% | -196.24% | -2.71% |
| Total Other Non-Cash Items | 0.00% | -108.60% | 2.12% | -26.19% | -2.77% |
| Change in Net Operating Assets | -- | -- | -2.09% | -- | -- |
| Cash from Operations | -0.32% | 8.86% | -2.12% | 30.76% | 2.75% |
| Capital Expenditure | -0.45% | 31.81% | -2.18% | -112.21% | 2.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -70.13% | -2.67% | 45.26% | 2.84% |
| Cash from Investing | -0.35% | 21.01% | -2.09% | -63.18% | 2.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -48.66% | 0.00% | 25.85% | 0.00% |
| Issuance of Common Stock | -- | -- | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -0.32% | -106.71% | 2.12% | 1,715.61% | 2.71% |
| Foreign Exchange rate Adjustments | 0.36% | 241.72% | -2.17% | -273.97% | -2.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.31% | -188.80% | 2.12% | 169.17% | 2.74% |